Vaishali Pharma Limited (VAISHALI) — Capital Reinvestment Ratio

Latest as of September 2025: 0.22x

Vaishali Pharma Limited (VAISHALI) has a Capital Reinvestment Ratio of 0.22x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs20.46 Million) in capital expenditures (Rs4.60 Million). Check Vaishali Pharma Limited tangible book value ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.22x
Capex / Operating Cash Flow

Operating Cash Flow

Rs20.46 Million
INR

Capital Expenditures

Rs4.60 Million
INR

Data as of

Sep 2025
Most recent filing

Vaishali Pharma Limited Capital Reinvestment Ratio (2013–2026)

This chart tracks Vaishali Pharma Limited's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Vaishali Pharma Limited cash conversion from operations.

Annual Capital Reinvestment Ratio for Vaishali Pharma Limited (2013–2026)

Year-by-year Capital Reinvestment Ratio for Vaishali Pharma Limited from 2013 to 2026. See Vaishali Pharma Limited free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (INR) Capital Expenditures YoY Change
2026 1.05x Rs4.36 Million Rs4.59 Million ▲ +665.6%
2024 0.14x Rs8.07 Million Rs1.11 Million ▼ -50.0%
2023 0.28x Rs10.80 Million Rs2.97 Million ▼ -58.0%
2022 0.66x Rs13.19 Million Rs8.65 Million ▲ +946.8%
2021 0.06x Rs20.11 Million Rs1.26 Million ▲ +283.4%
2020 0.02x Rs32.19 Million Rs526.04K ▼ -84.3%
2019 0.10x Rs28.48 Million Rs2.96 Million ▲ +2431.8%
2017 0.00x Rs8.52 Million Rs35.00K ▼ -77.7%
2016 0.02x Rs45.88 Million Rs847.00K ▲ +469.9%
2013 0.00x Rs37.97 Million Rs123.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow